Even though there is evidence suggesting that the type I IFN pathway is involved in tumor surveillance [28,29], to date, IFN blockade has not been associated with CML, and there have been no reports of spontaneous tumor formation in IFNAR-deficient mice. The gene discussed is IFNA1; the disease is neoplasm.